好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2022 Annual Meeting Virtual Experience | C38 - Disruptive Technologies and Neurology: Artificial Intelligence

Tuesday 04/26/22
04:00 PM - 05:00 PM EDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Mark Mintz, MD, FAAN
Eric Anderson, MD, PhD, FAAN
Practice, Policy, and Ethics
Participants will be provided an overview of the utilization and impact of artificial intelligence and related technologies in clinical practice. There will be in depth exploration of technologies for augmenting diagnostic acumen and accuracy. 
1.00 CME credit
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
04:00 PM - 04:25 PM EDT Speaker Artificial Intelligence: Impact on Clinical Practice
Mark Mintz, MD, FAAN
04:25 PM - 04:45 PM EDT Speaker Computers and Diagnosis: Artificial Intelligence Versus Augmented Intelligence
Michael M. Segal, MD, PhD
04:45 PM - 05:00 PM EDT Q&A Questions and Answers
Mark Mintz, MD, FAAN, Michael M. Segal, MD, PhD
Faculty Disclosures
Michael M. Segal, MD, PhD Dr. Segal has received personal compensation for serving as an employee of SimulConsult. Dr. Segal has stock in SimulConsult. Dr. Segal has received research support from NIH. Dr. Segal has received intellectual property interests from a discovery or technology relating to health care.
Mark Mintz, MD, FAAN Dr. Mintz has nothing to disclose.
Eric Anderson, MD, PhD, FAAN Dr. Anderson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Sindler Law firm, WVU, MayerLLP, KBA attorneys. Dr. Anderson has stock in Synapticure. The institution of Dr. Anderson has received research support from NIH.